Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 20 open reading frame 30 pseudogene is a non-coding genomic sequence on human chromosome 20 that shares homology with a putative protein-coding gene but is unable to produce a functional protein product due to disabling mutations or loss of regulatory elements. Pseudogenes like this may play minor regulatory roles at the RNA level, such as acting as competing endogenous RNAs or serving as sources of small regulatory RNAs, although most are functionless DNA remnants and not subjects of therapeutic targeting. The existence of the pseudogene is a result of gene duplication, retrotransposition, or other genomic events, and it is annotated according to systematic genomic conventions for open reading frames and pseudogenes[1][2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 20 open reading frame 30 pseudogene.